FDA Approved: ERMEZA — Original Application (Viatris Specialty LLC)

View source ↗

Summary

ERMEZA has been approved by the FDA through an original NDA for levothyroxine sodium, a thyroid hormone replacement used to treat hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• ERMEZA (LEVOTHYROXINE SODIUM)

Snippet

ORIG AP for ERMEZA (LEVOTHYROXINE SODIUM)